Get Started

QGEN

NYSE QIAGEN NV
Oct 23, 2026 · 10:12 AM ET DELAYED Market Open

$50.39 ↑ +0.17 (+0.34%) Trading Up from the previous close of $50.22, $0.05 below the day’s high of $50.44

YTD change
+12.05%
vs 20-day SMA
+10.20%
vs 200-day SMA
+18.52%

Price ranges

Previous day
$49.90 $50.52
open $50.47 close $50.22
-$0.25 (-0.50%)
Today
$50.36 $50.44
open $50.36 now $50.39
+$0.03 (+0.06%)
Past week
$45.84 $50.82
from $46.17 now $50.39
+$4.22 (+9.14%)
Past month
$41.94 $50.82
from $44.56 now $50.39
+$5.83 (+13.08%)
This year
$32.53 $57.82
from $44.97 now $50.39
+$5.42 (+12.05%)

Price & Performance

+12.25 (+32.26%) / 6M

$31.22$38.02$44.83$51.63Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 14.6% away from all-time highs of $59.00
  • QGEN is up 12% since the beginning of the year
  • QGEN is up 2% over the past 12 months
  • QGEN is up 13% over the past 1 month
  • 4% of all QGEN investors are betting against QGEN
  • Number of investors short QGEN has gone up 2% versus last month

QGEN reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +1.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.62
Earnings momentum +1.0% Quarterly EPS growth
Quarterly change +1.0%

Valuation

P/E ratio 26.04
Enterprise value $11.3B
Beta 0.44

Balance sheet & scale

Income$409.3K
Revenue$2.1B
Cash$793.5M
Debt$1.6M
Income / Debt 0.25×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $10.4B

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $34.40 +0.35%
ARGX argenx SE Sponsored ADR $875.76 -1.61%
ONC BeOne Medicines Ltd. Sponsored ADR $382.27 -1.08%
INCY Incyte Corporation $116.93 +3.08%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $11.52 -10.70%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.